216 related articles for article (PubMed ID: 29304269)
1. Hemorrhagic Ischemic Retinal Vasculitis and Alopecia Areata as a Manifestation of HLA-B27.
Sharma R; Randhawa S
Ophthalmic Surg Lasers Imaging Retina; 2018 Jan; 49(1):60-63. PubMed ID: 29304269
[TBL] [Abstract][Full Text] [Related]
2. Secondary Coats' response to retinal vasculitis managed with bevacizumab.
Chaudhary P; Varshney A; Videkar C
Indian J Ophthalmol; 2018 Sep; 66(9):1355-1357. PubMed ID: 30127171
[TBL] [Abstract][Full Text] [Related]
3. Retinal Vasculitis in Anti-Synthetase Syndrome.
Donovan CP; Pecen PE; Baynes K; Ehlers JP; Srivastava SK
Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):874-9. PubMed ID: 27631486
[TBL] [Abstract][Full Text] [Related]
4. Hemorrhagic Occlusive Retinal Vasculitis After First Eye Cataract Surgery Without Subsequent Second Eye Involvement.
Balducci N; Savini G; Barboni P; Ducoli P; Ciardella A
Ophthalmic Surg Lasers Imaging Retina; 2016 Aug; 47(8):764-6. PubMed ID: 27548454
[TBL] [Abstract][Full Text] [Related]
5. The clinical characteristics of retinal vasculitis in HLA-B27-positive patients.
Braakenburg AM; Rothova A
Ocul Immunol Inflamm; 2014 Jun; 22(3):197-202. PubMed ID: 24102118
[TBL] [Abstract][Full Text] [Related]
6. Retinal Vasculitis in a Patient with Ankylosing Spondylitis: A rare Association.
Majumder AK; Roy R; Sitaula RK; Magesan K; Majumder PD
Nepal J Ophthalmol; 2018 Jan; 10(19):86-89. PubMed ID: 31056582
[TBL] [Abstract][Full Text] [Related]
7. Fluorescein Angiography Versus Optical Coherence Tomography Angiography in Macular Telangiectasia Type I Treated With Bevacizumab Therapy.
Yannuzzi NA; Gregori NZ; Roisman L; Gupta N; Goldhagen BE; Goldhardt R
Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):263-266. PubMed ID: 28297041
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids.
Sein J; Tzu JH; Murray TG; Berrocal AM
Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):443-9. PubMed ID: 27183548
[TBL] [Abstract][Full Text] [Related]
9. Bilateral idiopathic retinal vasculitis following coxsackievirus A4 infection: a case report.
Mine I; Taguchi M; Sakurai Y; Takeuchi M
BMC Ophthalmol; 2017 Jul; 17(1):128. PubMed ID: 28724375
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice.
Khan M; Wai KM; Silva FQ; Srivastava S; Ehlers JP; Rachitskaya A; Babiuch A; Deasy R; Kaiser PK; Schachat AP; Yuan A; Singh RP
Ophthalmic Surg Lasers Imaging Retina; 2017 Jun; 48(6):465-472. PubMed ID: 28613352
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic Occlusive Retinal Vasculopathy.
Lee SM; Kang HG; Kim M
Ophthalmol Retina; 2021 Nov; 5(11):1096. PubMed ID: 34752303
[No Abstract] [Full Text] [Related]
12. Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis.
Wong R; Gupta B; Stanford MR; Laidlaw DA
Int Ophthalmol; 2010 Aug; 30(4):415-9. PubMed ID: 20012158
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes.
Witkin AJ; Chang DF; Jumper JM; Charles S; Eliott D; Hoffman RS; Mamalis N; Miller KM; Wykoff CC
Ophthalmology; 2017 May; 124(5):583-595. PubMed ID: 28110950
[TBL] [Abstract][Full Text] [Related]
14. Retinal Vasculitis in Kawasaki Disease.
Agarwal S; Mulkutkar S; Suri D; Singh S; Gupta A
Indian J Pediatr; 2015 Dec; 82(12):1183-4. PubMed ID: 25990595
[No Abstract] [Full Text] [Related]
15. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
Kim KH; Kim JH; Chang YS; Lee TG; Kim JW; Lew YJ
Korean J Ophthalmol; 2015 Oct; 29(5):315-24. PubMed ID: 26457037
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
[TBL] [Abstract][Full Text] [Related]
17. HEMORRHAGIC VASCULITIS AND RETINOPATHY HERALDING AS AN EARLY SIGN OF BACTERIAL ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION.
Conrady CD; Feistmann JA; Roller AB; Boldt HC; Shakoor A
Retin Cases Brief Rep; 2019; 13(4):329-332. PubMed ID: 28594738
[TBL] [Abstract][Full Text] [Related]
18. Optical Coherence Tomography Features in Diabetic Macular Edema and the Impact on Anti-VEGF Response.
Itoh Y; Petkovsek D; Kaiser PK; Singh RP; Ehlers JP
Ophthalmic Surg Lasers Imaging Retina; 2016 Oct; 47(10):908-913. PubMed ID: 27759856
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.
Witkin AJ; Shah AR; Engstrom RE; Kron-Gray MM; Baumal CR; Johnson MW; Witkin DI; Leung J; Albini TA; Moshfeghi AA; Batlle IR; Sobrin L; Eliott D
Ophthalmology; 2015 Jul; 122(7):1438-51. PubMed ID: 25886796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
